This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowman, C. C.
Right arrow Articles by Clements, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowman, C. C.
Right arrow Articles by Clements, J. D.

 Previous Article  |  Next Article 

Infection and Immunity, March 2001, p. 1528-1535, Vol. 69, No. 3
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.3.1528-1535.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Differential Biological and Adjuvant Activities of Cholera Toxin and Escherichia coli Heat-Labile Enterotoxin Hybrids

Christal C. Bowman and John D. Clements*

Program in Molecular Pathogenesis and Immunity, Department of Microbiology and Immunology, Tulane University Health Science Center, New Orleans, Louisiana 70112

Received 25 August 2000/Returned for modification 11 October 2000/Accepted 22 November 2000

Two bacterial products that have been demonstrated to function as mucosal adjuvants are cholera toxin (CT), produced by various strains of Vibrio cholerae, and the heat-labile enterotoxin (LT) produced by some enterotoxigenic strains of Escherichia coli. Although LT and CT have many features in common, they are clearly distinct molecules with biochemical and immunologic differences which make them unique. The goal of this study was to determine the basis for these biological differences by constructing and characterizing chimeric CT-LT molecules. Toxin gene fragments were subcloned to create two constructs, each expressing the enzymatically active A subunit of one toxin and the receptor binding B subunit of the other toxin. These hybrid toxins were purified, and the composition and assembly of CT A subunit (CT-A)-LT B subunit (LT-B) and LT A subunit (LT-A)-CT B subunit (CT-B) were confirmed. Hybrids were evaluated for enzymatic activity, as measured by the accumulation of cyclic AMP in Caco-2 cells, and the enterotoxicity of each toxin was assessed in a patent-mouse assay. The results demonstrated that LT-A-CT-B induces the accumulation of lower levels of cyclic AMP and has less enterotoxicity than either wild-type toxin or the other hybrid. Nonetheless, this hybrid retains adjuvant activity equivalent to or greater than that of either wild-type toxin or the other hybrid when used in conjunction with tetanus toxoid for intranasal immunization of BALB/c mice. Importantly, the ability of LT to induce a type 1 cytokine response was found to be a function of LT-A. Specifically, LT-A-CT-B was able to augment the levels of antigen-specific gamma interferon (IFN-gamma ) and interleukin 5 to levels comparable to those achieved with native LT, while CT-A-LT-B and native CT both produced lower levels of antigen-specific IFN-gamma . Thus, these toxin hybrids possess unique biological characteristics and provide information about the basis for differences in the biological activities observed for CT and LT.


* Corresponding author. Mailing address: Program in Molecular Pathogenesis and Immunity, Department of Microbiology and Immunology, 1430 Tulane Ave., Tulane University Health Science Center, New Orleans, LA 70112. Phone: (504) 588-5070. Fax: (504) 588-5144. E-mail: jclemen{at}tulane.edu.


Infection and Immunity, March 2001, p. 1528-1535, Vol. 69, No. 3
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.3.1528-1535.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Olivier, V., Salzman, N. H., Satchell, K. J. F. (2007). Prolonged Colonization of Mice by Vibrio cholerae El Tor O1 Depends on Accessory Toxins. Infect. Immun. 75: 5043-5051 [Abstract] [Full Text]  
  • Li, C., Dandridge, K. S., Di, A., Marrs, K. L., Harris, E. L., Roy, K., Jackson, J. S., Makarova, N. V., Fujiwara, Y., Farrar, P. L., Nelson, D. J., Tigyi, G. J., Naren, A. P. (2005). Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. JEM 202: 975-986 [Abstract] [Full Text]  
  • Aloni-Grinstein, R., Gat, O., Altboum, Z., Velan, B., Cohen, S., Shafferman, A. (2005). Oral Spore Vaccine Based on Live Attenuated Nontoxinogenic Bacillus anthracis Expressing Recombinant Mutant Protective Antigen. Infect. Immun. 73: 4043-4053 [Abstract] [Full Text]  
  • Horstman, A. L., Bauman, S. J., Kuehn, M. J. (2004). Lipopolysaccharide 3-Deoxy-D-manno-octulosonic Acid (Kdo) Core Determines Bacterial Association of Secreted Toxins. J. Biol. Chem. 279: 8070-8075 [Abstract] [Full Text]  
  • Foy, B. D., Magalhaes, T., Injera, W. E., Sutherland, I., Devenport, M., Thanawastien, A., Ripley, D., Cardenas-Freytag, L., Beier, J. C. (2003). Induction of Mosquitocidal Activity in Mice Immunized with Anopheles gambiae Midgut cDNA. Infect. Immun. 71: 2032-2040 [Abstract] [Full Text]  
  • Boyaka, P. N., Ohmura, M., Fujihashi, K., Koga, T., Yamamoto, M., Kweon, M.-N., Takeda, Y., Jackson, R. J., Kiyono, H., Yuki, Y., McGhee, J. R. (2003). Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit. J. Immunol. 170: 454-462 [Abstract] [Full Text]  
  • Arrington, J., Braun, R. P., Dong, L., Fuller, D. H., Macklin, M. D., Umlauf, S. W., Wagner, S. J., Wu, M. S., Payne, L. G., Haynes, J. R. (2002). Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coli Are Strong Adjuvants for DNA Vaccines. J. Virol. 76: 4536-4546 [Abstract] [Full Text]